LA JOLLA, Calif., Feb. 7 /PRNewswire/ -- Advanced Tissue Sciences, Inc.
(Nasdaq: ATIS) will announce its year end 2000 results on Monday, February 12,
2001.
In addition to the release of the year end results, Advanced Tissue
Sciences is scheduled to present at the 38th Institutional Investor Conference
sponsored by the Wall Street Analyst Forum. The meeting will be held at the
Roosevelt Hotel in New York City on February 12-16, 2001. Arthur J.
Benvenuto, Chairman and Chief Executive Officer, and Nikhil A. Mehta, Chief
Financial Officer, will present an overview of the Company's business strategy
and programs on Monday, February 12, 2001 at 11:50 a.m. EST.
You may view and listen to the presentation over the Internet by visiting
our web site at http://www.advancedtissue.com. For those who cannot listen to the
live broadcast, a replay will be available on our web site until 8:00 p.m. EST
on Monday, February 19, 2001.
Advanced Tissue Sciences is a tissue engineering company utilizing its
proprietary core technology to develop and manufacture human-based tissue
products for tissue repair and transplantation. The Company has two joint
ventures with Smith & Nephew plc. The first covers the application of
Advanced Tissue Sciences' tissue engineering technology for skin wounds and
includes Dermagraft(R) for the treatment of diabetic foot ulcers,
TransCyte(TM) for the temporary covering of second and third-degree burns and
future developments for venous ulcers, pressure ulcers, burns and other
non-aesthetic wound care treatments. The second joint venture is developing
tissue-engineered orthopedic cartilage, initially focusing on the repair of
cartilage in knee joints. The Company also has a strategic alliance with
Inamed Corporation for the development and marketing of several of Advanced
Tissue Sciences' human-based, tissue-engineered products for aesthetic and
certain reconstructive applications. In addition, the Company is developing
products for cardiovascular applications. For more information on Advanced
Tissue Sciences visit our web site at http://www.advancedtissue.com.
SOURCE Advanced Tissue Sciences, Inc.
 back to top
Related links:
http://www.advancedtissue.com
Company News On-Call:
http://www.prnewswire.com/comp/532975.html or fax,
800-758-5804, ext. 532975
CONTACT:
Jana Stoudemire, Senior Director, Corporate
Communications of Advanced Tissue Sciences, Inc., 858-713-7802
|
